PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
$0.94-4.96%
报价 2026-11-13
市值
$20.9M
EV
$23M
PE (TTM)
–
预期 PE (FY2027)
13.4x
52 周区间距高点 -75.9%
$0.94$3.90
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PETSPetMed Express, Inc. | $20.9M | -5.0% | +1.0% | 27.6% | – | – | – | |
| BDSXBiodesix, Inc. | $80.4M | +0.9% | +29.1% | 63.9% | – | – | – | |
| FBIOFortress Biotech, Inc. | $62.7M | -5.5% | +31.4% | 64.5% | 1.0x | – | 0.8x | |
| RNTXRein Therapeutics Inc. | $47.6M | -1.4% | – | 0% | – | – | – | |
| MDAISpectral AI, Inc. | $41.8M | -3.7% | +1.1% | 41.5% | – | – | – | |
| TELATELA Bio, Inc. | $37.1M | -4.6% | +7.8% | 67.2% | – | – | – | |
| YI111, Inc. | $25M | -0.4% | – | 5.7% | – | – | – | |
| CTSOCytosorbents Corporation | $15.3M | -9.3% | +8.0% | 71.6% | – | – | – | |
| MDCXMedicus Pharma Ltd. | $2.8M | +13.4% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +8.0% | 52.7% | 1.0x | – | 0.8x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q2 2027 | 2026-06-30 Q1 2027 | 2026-03-31 Q4 2026 | 2025-12-31 Q3 2026 | 2025-09-30 Q2 2026 | 2025-06-30 Q1 2026 | 2025-03-31 Q4 2025 | 2024-12-31 Q3 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.8M | $41M | $42.8M | $40.7M | $44.4M | $51.2M | $46.5M | $53M |
| Gross Margin | 27.4% | 27.6% | 16% | 23.3% | 28% | 23.7% | 40.8% | 28.1% |
| Operating Margin | -17.9% | -15.2% | -13.3% | -25.7% | -18.9% | -13.4% | -13% | -0.8% |
| Net Income | $-6.4M | $-6.1M | $-4.1M | $-10.6M | $-8.5M | $-34.2M | $-11.6M | $-707,000 |
| Diluted EPS | -0.31 | -0.28 | -0.19 | -0.5 | -0.41 | -1.65 | -0.56 | -0.03 |
| Operating Cash Flow | $-1.1M | $-7.7M | $-4.7M | $-9.2M | $-2.2M | $-12.3M | $7M | $-1.2M |
研究材料
Filing 摘要
暂无 filing 摘要。
电话会纪要摘要
暂无纪要摘要。